Evidence map›Paper›PMID 39971882›Full record

ReviewHormones (Athens, Greece)2025

GLP-1RAs in patients with psoriasis.

Ioanna A Paschou, Evangelia Sali, Stavroula A Paschou, Theodora Psaltopoulou, Electra Nicolaidou, Alexander J Stratigos

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. The effects of GLP-1RA on inflammatory skin diseases: A comprehensive review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ioanna A Paschou1st Department of Dermatology and Venereology, "Andreas Sygros" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Evangelia SaliEndocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Stavroula A PaschouEndocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.ORCID http://orcid.org/0000-0002-0651-1376
Theodora PsaltopoulouEndocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Electra Nicolaidou1st Department of Dermatology and Venereology, "Andreas Sygros" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Alexander J Stratigos1st Department of Dermatology and Venereology, "Andreas Sygros" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. alstrat@med.uoa.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GLP-1RAPsoriasisSkinType 2 diabetes

Identifiers

PMID39971882
PMCPMC12339632

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.